Posted on by sciencefatherLeave a Comment on Ana Perona-Moratalla | Medicine | Best Researcher Award
77 / 100
Powered by Rank Math SEO

Dr. Ana Perona-Moratalla | Medicine | Best Researcher Award

Neurologist at Servicio de Salud de Castilla-La Mancha, Spain.

🌍Dr. Ana Belén Perona Moratalla, a Neurology Specialist at the Complejo Hospitalario Universitario de Albacete since 2016, is a distinguished researcher and clinician. She completed her Neurology training with excellence and pursued advanced studies, including a master’s degree in Movement Disorders and a doctoral focus on von Hippel-Lindau disease. She leads the Movement Disorders Unit and has made significant contributions to stroke protocols, deep brain stimulation in Parkinson’s disease, and dementia diagnosis through biomarkers. With over 39 conference presentations, 13 high-quality publications, and active participation in clinical trials, her work bridges clinical care and innovative research. She also teaches at the University of Castilla-La Mancha, mentoring undergraduate and postgraduate students.

Profile👤

Education 🎓

🎓Dr. Perona completed her Neurology specialization (2005-2009) at the Hospital General Universitario de Albacete, earning an excellence evaluation. She further specialized in movement disorders at London’s National Hospital of Neurology and Neurosurgery. During her residency, she pursued doctoral coursework at Universidad Autónoma de Madrid. Between 2011-2013, she obtained a Master’s in Movement Disorders from Universidad de Murcia. Currently a Ph.D. candidate at Universidad de Castilla-La Mancha, her research explores hemangioblastomas in von Hippel-Lindau disease.🎓

Experience💼

🩺Since 2009, Dr. Perona has served as Adjunct Physician at Hospital General Universitario de Albacete, with a tenure at Hospital General de Almansa (2013-2016), where she developed ischemic stroke protocols. She specializes in deep brain stimulation, advanced neurodiagnostics, and cerebrovascular interventions. Dr. Perona actively participates in functional neurosurgery for movement disorders and has guided EEG analysis, neuro-oncology research, and patient care protocols👨‍🔬🌍

Research Interests 🔬

🔬Dr. Perona’s research encompasses movement disorders, ischemic stroke, and neuro-oncology. Her work in cerebrovascular biomarker identification and deep brain stimulation efficacy for Parkinson’s disease has advanced therapeutic approaches. She also investigates hemangioblastomas linked to von Hippel-Lindau disease, collaborating on translational research and clinical trials.🌿🧪

Awards and Honors 🏆

Dr. Perona has received recognition for her groundbreaking contributions to neurology, including commendations for establishing innovative diagnostic protocols and presenting at international conferences. She has contributed to 39 congresses and authored multiple high-impact publications. Her collaborative work in clinical trials has gained widespread acclaim.

Conclusion 🔚 

Dr. Perona Moratalla demonstrates a robust portfolio of clinical excellence, research innovation, and academic dedication, making her a strong candidate for the Best Researcher Award. Her work significantly impacts neurology, with potential to grow further through enhanced research visibility and global engagement. This award would not only honor her achievements but also encourage her continued contributions to the field.

Publications Top Notes 📚

Emergency nursing staff’s well-being, burnout, and sleep on 12-hour shifts

Authors: Sánchez Onrubia, I.M., Resta Sánchez, E.J., Cabañero Contreras, T., Perona Moratalla, A.B., Molina Alarcón, M.
Year: 2024
Citations: 0

Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry

Authors: Romero-Sánchez, C.M., Díaz-Maroto, I., Fernández-Díaz, E., Ahmad, J., Segura, T.
Year: 2020
Citations: 595

Isolation and Quantification of Blood Apoptotic Bodies, a Non-invasive Tool to Evaluate Apoptosis in Patients with Ischemic Stroke and Neurodegenerative Diseases

Authors: Serrano-Heras, G., Díaz-Maroto, I., Castro-Robles, B., Ayo-Martín, O., Segura, T.
Year: 2020
Citations: 23

Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia

Authors: Sanchez-Larsen, A., Sopelana, D., Diaz-Maroto, I., Palazón-García, E., Segura, T.
Year: 2018
Citations: 32

Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel–Lindau patients

Authors: Albiñana, V., Villar Gómez De Las Heras, K., Serrano-Heras, G., De Campos, J.M., Botella, L.M.
Year: 2015
Citations: 37

Contribution of ultrasound in a patient with motor neuropathy with blocks

Authors: Pardal-Fernández, J.M., Arciniegas, A., Perona-Moratalla, A.B., García-García, J.
Year: 2014
Citations: 0

Deep brain stimulation in Parkinson’s disease

Authors: Díaz-Maroto, I., Fernández-Díaz, E., Palazón-García, E., Perona-Moratalla, A.B., García Muñozguren, S.
Year: 2012
Citations: 6

Post-electrocution delayed myelopathy

Authors: Pardal-Fernández, J.M., Perona-Moratalla, A.B., Rodríguez-Vázquez, M.
Year: 2012
Citations: 0

Non-motor disorders in Parkinson’s disease: Introduction and general features

Authors: Argandoña-Palacios, L., Perona-Moratalla, A.B., Hernández-Fernández, F., Díaz-Maroto, I., García-Muñozguren, S.
Year: 2010
Citations: 7

Utility of in situ thrombolysis in patients with cerebral venous thrombosis

Authors: Hernández-Fernández, F., Perona-Moratalla, A.B., Segura, T.
Year: 2009
Citations: 0

 

 

Ana Perona-Moratalla | Medicine | Best Researcher Award

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *